Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Joubert

Showing results (91-100 of 163) with videos related to

Pageof 17
Sort By:
The American Journal of Surgical Pathology|May 16, 2017
A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 FusionsPatrice Desmeules, Philippe Joubert, Lei Zhang, et al.
Histopathology|November 13, 2023
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologistsKeith M Kerr, Lukas Bubendorf, Fernando Lopez-Rios, et al.
The International Journal of Developmental Biology|January 4, 2019
Lung cancer susceptibility genetic variants modulate HOXB2 expression in the lungAlisson Clemenceau, Olivier Boucherat, Kim Landry-Truchon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 20, 2022
Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never SmokersLouis-Jacques Ruel, Zhonglin Li, Nathalie Gaudreault, et al.
Immunity|April 15, 2014
Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophagesFrançois Coulombe, Joanna Jaworska, Mark Verway, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi ProcessJames Tankel, Jonathan Spicer, Quincy Chu, et al.
Cancers|January 23, 2024
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary StudyAbdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2026
Integrating Histologic Descriptors into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung AdenocarcinomaHanie Abolfathi, Michael Maranda-Robitaille, Fabien Claude Lamaze, et al.
Clinical Transplantation|March 8, 2021
Non-invasive diagnostic imaging tests largely underdiagnose cardiac cirrhosis in patients undergoing advanced therapy evaluation: How can we identify the high-risk patient?David Belzile, Pierre Yves Turgeon, Evelyne Leblanc, et al.
Oncogene|March 26, 2025
ZNF768 loss amplifies p53 action and reduces lung tumorigenesis in miceAudrey Poirier, Timon Utecht, Romain Villot, et al.
Pageof 17

Showing results (91-100 of 163) with videos related to

Sort By:
Pageof 17
The American Journal of Surgical Pathology|May 16, 2017
A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 FusionsPatrice Desmeules, Philippe Joubert, Lei Zhang, et al.
Histopathology|November 13, 2023
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologistsKeith M Kerr, Lukas Bubendorf, Fernando Lopez-Rios, et al.
The International Journal of Developmental Biology|January 4, 2019
Lung cancer susceptibility genetic variants modulate HOXB2 expression in the lungAlisson Clemenceau, Olivier Boucherat, Kim Landry-Truchon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 20, 2022
Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never SmokersLouis-Jacques Ruel, Zhonglin Li, Nathalie Gaudreault, et al.
Immunity|April 15, 2014
Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophagesFrançois Coulombe, Joanna Jaworska, Mark Verway, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi ProcessJames Tankel, Jonathan Spicer, Quincy Chu, et al.
Cancers|January 23, 2024
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary StudyAbdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2026
Integrating Histologic Descriptors into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung AdenocarcinomaHanie Abolfathi, Michael Maranda-Robitaille, Fabien Claude Lamaze, et al.
Clinical Transplantation|March 8, 2021
Non-invasive diagnostic imaging tests largely underdiagnose cardiac cirrhosis in patients undergoing advanced therapy evaluation: How can we identify the high-risk patient?David Belzile, Pierre Yves Turgeon, Evelyne Leblanc, et al.
Oncogene|March 26, 2025
ZNF768 loss amplifies p53 action and reduces lung tumorigenesis in miceAudrey Poirier, Timon Utecht, Romain Villot, et al.
Pageof 17